Eye drops redefined
An eye for innovation in eye care
EYE-GO
Administering topical eye medication is a massive challenge for patients in particular for seniors and children, but also for all other age groups. This potentially results in poor treatment outcomes, low compliance, blindness and poor quality of life.
EYE-GO is an international development stage company, with focus on solving the above issues by use of innovative device technology
PATIENTS and casual users also experience DIFFICULTIES with the eye drop bottle
Difficult to aim / Difficult to squeeze / Overdosing – every time / Adverse events
DROP BOTTLE issues are key to LOW COMPLIANCE
Only 10% of glaucoma patients are treatment compliant
Approx. 120.000 Americans are blind from glaucoma
Non compliance causes blindness
We have a solution
Precise dosing through a mist technology
Precise delivery of the medication
Easy to handle device – even with low dexterity
Preservative free formulations
Range of viscosities
Increase compliance
News
EYE-GO Closes major investment round with existing investors and Maj Invest Holding, one of the most successful capital funds in Denmark.
EYE-GO partners up with DTU on Master Project in a virgin field of research within ophthalmology
2018/10 new CEO take over leadership of company. 20+ years of international management experience in world-leadning Life Science companies. Focused on bringing medical devices from idea to market in the fastest and most efficient way. Previous roles includes VP in Coloplast and Ambu
EYE-GO patents have been granted in US and Europe. New patents submitted and new, international customer in place
Strong team in medical devices
We work together as one team of people with expertise and determination to achieve our goals collectively. Our values of respect, trust, and appreciation are at the very core of our foundation.
Management
Executive Board
Board Chairman
Christian Stig Moeller
GM Fisher Investments
Board member
Ole Feddersen
Novo Nordisk
Board member
Joachim Vanggaard
Maj Invest Holding
Advisory
Commercial
Bent Johnsen
Ex- Novo Nordisk, PNL
Development Engineering
Kurt Solgaard
DTU – Technical University of Denmark – Institute for Mechanical Engineering
Rigshospitalets Øjenafdeling (National Hospital of Denmark, Ophthalmic ward and research unit)